Stocks · Health care · Services-Commercial Physical & Biological Research

MAXCYTE, INC.

MXCT Clue Score24
United States Fiscal year ends December CIK 0001287098 Results filed 14 Oct 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
0.6×

Maher Masoud holds only 0.6 times base salary in stock. $387.13K of shares against $590.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Maher Masoud last reported holding, valued at $0.82, the price Common Stock was last bought or sold at on the open market here, on 17 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Maher Masoud
President and CEO
—
—
—
475,000
$387.13K
+375.0%
Stanley C Erck
Director
—
—
—
428,749
$349.43K
+59.3%
Richard Douglas
Director
—
—
—
260,998
$212.71K
+115.0%
John Joseph Johnston
Director
—
—
—
201,581
$164.29K
+42.0%
Parmeet Ahuja
Chief Financial Officer
—
—
—
187,500
$152.81K
—
William W Brooke
Director
—
—
—
181,300
$147.76K
+153.0%
Douglas J Swirsky
Chief Financial Officer
—
—
—
151,669
$123.61K
+86.7%
Cynthia Collins
Director
—
—
—
111,310
$90.72K
+115.4%
Patrick J Balthrop
Director
—
—
—
80,998
$66.01K
+279.1%
Yasir B. Al-Wakeel
Director
—
—
—
80,998
$66.01K
+279.1%
Rekha Hemrajani
Director
—
—
—
70,314
$57.31K
+229.1%
David I. Sandoval
General Counsel
—
—
—
64,219
$52.34K
+39.9%
Ali Soleymannezhad
Chief Commercial Officer
—
—
—
59,439
$48.44K
+128.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.